What is the main business of Kilinika Femmed?

The main business activity of Kilinika Femmed focuses on specialist medical practice activities.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on April 28, 2020.

Where is the headquarters located?

The headquarters is located at: ul. Stogi 9B, 03-289 Warszawa.

What is the share capital?

The share capital of the company is PLN 35,000 (approx. $9,454).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What was the revenue?

In 2025, the company generated total revenue of $347,843, representing a decrease of 20.2% compared to 2024.

Yes, in 2025 the company was profitable, achieving a net profit of $7,589, meaning the company decreased its profit by 88.0%.

Which cost dominates operating expenses?

The largest operating cost category falls under materials and energy. This category amounted to $191,716 in 2025, representing 56% of all operating expenses.

Kilinika Femmedsp. z o.o.

Specialist medical practice activities

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2020-04-28

Share capital

35,000.00 PLN

Registered address

ul. Stogi 9B, 03-289 Warszawa, Poland

Electronic delivery address

AE:PL-44054-51115-GFIWC-22

Financials

Revenue history (in k)

Filing timeliness

3 of 6 financial statements were filed late (the longest delay 549 days for 2023).

202518/06/2026
202415/01/2026
202315/01/2026
202210/07/2023
202115/10/2022
202015/10/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 347.84kMedianUSD 443.52kAverageUSD 1.75m

Net profit

This companyUSD 7.59kMedianUSD 14.31kAverageUSD 129.53k

Operating costs

This companyUSD 339.50kMedianUSD 397.10kAverageUSD 1.56m

Assets

This companyUSD 338.22kMedianUSD 173.92kAverageUSD 1.02m

Industry

Specialist medical practice activities (86.22.Z)Primary
Other out-of-school forms of education, not elsewhere classified (85.59.B)
Medical and dental practice activities (86.2)

Authorized Representatives

Andrzej Roman Eberhardt – President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Andrzej Roman Eberhardtage 49	650	$225.10	2.3809%
Others	26,650	$9,229.25	97.6191%

Beneficial owners

Person	Rights

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Competitors

Name	Revenue	Website
Vivamedsp. z o.o.	$664,431.20	vivamed.com.pl
Klinika Holisp. z o.o.	$630,864.28	klinikaholi.pl
Klinika Kossutsp. z o.o.	$622,695.50	drkossut.pl
Nectar Polskasp. z o.o.	$528,123.00	klinikametoda.pl
Astimedsp. z o.o.	$498,540.18	astimed.pl
I. V. Clinicsp. z o.o.	$510,444.80	ivclinic.com.pl
MAAMsp. z o.o.	$455,593.52	urmed.pl
Saska Medsp. z o.o.	$241,826.45	saskamed.pl
Promindsp. z o.o.	$89,181.48	promindclinic.pl
Onkomedicasp. z o.o.	$69,344.55	onkomedica.pl